Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

1. Exploring Different Levels of Contact Frequency in Multiple Sclerosis Care.Brain and behavior · 2025
   Article
2. Subgroup analyses and patterns of multiple sclerosis health service utilisation: A cluster analysis.Multiple sclerosis journal - experimental, translational and clinical
   Article
3. Barriers to care for people with unclear visual loss-Data from a tertiary-level-of-care neuroinflammation center.Multiple sclerosis journal - experimental, translational and clinical
   Article

Corrections and comments

• Comment on
  Disease-modifying drugs for multiple sclerosis and subsequent health service use.2022
• Comment on
  Emergency medical care for multiple sclerosis: A five-year population study in the Campania Region (South Italy).2022

Authors and funding

2 authors at 1 institution in 1 country.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as